BioBeats – We're Cooking

研报英文原文证据摘录

BioBeats – We're Cooking

Biotechnology | Biotechnology |

Biotechnology

EQUITY RESEARCH Industry Report

June 26, 2026

Research Analysts:

Steve Seedhouse At the halfway mark of 2026, XBI is up ~25% YTD and this is one of

212-915-1240

Steve.Seedhouse@cantor.com the strongest M&A years on record (despite as Josh notes this week,

Josh Schimmer correlation of M&A/XBI performance has been low historically). This,

310-282-6513 despite a tumultuous and somewhat unpredictable year on the regulatory

Josh.Schimmer@cantor.com and arguably macroeconomic front. Check out *five* new Cantor initiations

Eric Schmidt + more in this week's BioBeats. 212-294-7724

Eric.Schmidt@cantor.com Click HERE for the link to the recording or open this report for the slides.

Prakhar Agrawal

212-610-3614

Prakhar.Agrawal@cantor.com BioBeats Trivia: Definium posted positive P3 MDD data for LSD.

Olivia Brayer Saunders

212-428-5907 ●What was Definium previously known as?

Olivia.Brayer@cantor.com ●What tech visionary credited his LSD experiences as “one of the two or Carter Gould

212-915-1794 three most important things” he had done in his life?

Carter.Gould@cantor.com

●What Nobel Laureate credited LSD for his inventing of PCR? Kristen Kluska

212-915-1927

Kristen.Kluska@cantor.com Ahead Next Week:

Imogen Mansfield

929-545-6495 ●Monday, June 29: Cantor hosting Catalyst Series Webinar with PHVS

Imogen.Mansfield@cantor.com (register HERE)

Yanni Souroutzidis

929-730-2656 ●Tuesday, June 30: Cantor hosting ALMS NDR in Europe (30th/1st)

Yanni.Souroutzidis@cantor.com

Pete Stavropoulos, Ph.D. News of the Week:

212-915-1966

Pete.Stavropoulos@cantor.com ●ABBV (2:40)

Li Watsek

212-915-1221 ●M&A Tracker (3:40)

Li.Watsek@cantor.com

●Debate of the Week (4:10)

Cantor Research Highlights:

●EGTX.SS (7:00)

●PYC (ASX) (7:55)